re: Ann: Strategic milestone underpins US rev... Now surely a company generating over $30m in global sales , spends $5m a year in R&D and has just realeased a number of new products is worth much more than $15m
Net debt is almost zero and cashflow supports its growth also if the business were sold it would go for 1.5 to 2 times sales.
We could compare them with numerous other medical device companies who have similar market caps but have virtually no sales and need capital.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $57.66M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.0¢ | 29.0¢ | $124.3K | 411.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33061 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 14.43pm 29/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |